Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Archer

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|November 1, 1986
ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dogS L Archer, E Chesler, J N Cohn, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1986
The effects of substance P on the preconstricted pulmonary vasculature of the anesthetized dogS L Archer, T J Kulik, E Chesler, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressureV Hampl, S L Archer, D P Nelson, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulationS L Archer, E K Weir, H L Reeve, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideE G DeMaster, L Raij, S L Archer, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factorS L Archer, J P Tolins, L Raij, et al.
The European Respiratory Journal|July 1, 1996
Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysisV Hampl, M Tristani-Firouzi, D P Nelson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertensionS L Archer, R D Yankovich, E Chesler, et al.
Cardiovascular Research|January 1, 1996
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertensionV Hampl, M Tristani-Firouzi, T C Hutsell, et al.
The American Journal of Physiology|September 14, 1999
Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potentialH L Reeve, S L Archer, M Soper, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|November 1, 1986
ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dogS L Archer, E Chesler, J N Cohn, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1986
The effects of substance P on the preconstricted pulmonary vasculature of the anesthetized dogS L Archer, T J Kulik, E Chesler, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressureV Hampl, S L Archer, D P Nelson, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulationS L Archer, E K Weir, H L Reeve, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideE G DeMaster, L Raij, S L Archer, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factorS L Archer, J P Tolins, L Raij, et al.
The European Respiratory Journal|July 1, 1996
Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysisV Hampl, M Tristani-Firouzi, D P Nelson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertensionS L Archer, R D Yankovich, E Chesler, et al.
Cardiovascular Research|January 1, 1996
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertensionV Hampl, M Tristani-Firouzi, T C Hutsell, et al.
The American Journal of Physiology|September 14, 1999
Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potentialH L Reeve, S L Archer, M Soper, et al.
Pageof 10